Gut Microbiota Dysbiosis in Mild Cognitive Impairment: Alzheimer’s Disease Diagnostic Potential and Nutritional Modulation
DOI:
https://doi.org/10.71341/bmwj.v3i1.50Keywords:
Alzheimer, microbiota, dysbiosis, neurodegenerationAbstract
Background:. Alzheimer’s disease (AD) is a progressively deteriorating neurodegenerative condition that poses a substantial burden on society. Current diagnostic methods of AD are often considered complex and costly. Mild Cognitive Impairment (MCI) is defined as the transitional stage before AD. Alterations in the gut microbiota (dysbiosis) are observed in MCI and preclinical AD and are hypothesized to contribute to disease pathogenesis.
Aim: The objective of this review was to evaluate gut microbiota profiles as non-invasive, low-cost indicators and tailor diagnostic biomarkers. The diagnostic potential and the efficacy of nutritional modulation strategies across the AD continuum were assessed.
Methods: The mechanisms by which dysbiosis promotes neurodegeneration were analyzed, including increased intestinal permeability, Lipopolysaccharide (LPS) leakage, and reduced production of short-chain fatty acids (SCFAs). Taxonomic shifts were summarized, documenting the depletion of SCFA producers (e.g., Firmicutes) and the enrichment of pro-inflammatory genera. The quantitative performance of machine learning models utilizing microbial data for disease classification was reviewed.
Results: High predictive accuracy for AD incidence was achieved by machine learning classifiers based solely on gut microbiome profiles, with Area Under the Curve (AU-ROC) values reaching up to 0.927. Nutritional interventions, including probiotics (Lactobacillus, Bifidobacterium) and prebiotics, were found to modulate the gut effectively by enhancing SCFA production, reinforcing intestinal barrier integrity, and suppressing systemic neuroinflammation.
Conclusion: Robust potential is demonstrated by gut microbial profiles as high-performance, non-invasive screening tools for early detection in the AD continuum. However, future validation is required through large-scale, long-term randomized controlled trials (RCTs) focusing on establishing causation and developing personalized gut-based therapies.
References
Aathira, N. S., Kaur, A., Kumar, A., Dar, G. M., Nimisha, Sharma, A. K., Bera, P., Mahajan, B., Chatterjee, A., & Saluja, S. S. (2025). The genetic risk factors, molecular pathways, microRNAs, and the gut microbiome in Alzheimer’s disease. In Neuroscience (Vol. 577, pp. 217–227). Elsevier Ltd. https://doi.org/10.1016/j.neuroscience.2025.05.021
Alaeddin, S., Chatterjee, A., Roberts, T. L., Steiner-Lim, G. Z., Jensen, S. O., Gyengesi, E., Muench, G., & Ho, V. (2025). Exploring the effects of faecal microbiota transplantation on cognitive function: A review of clinical trials. In Brain, Behavior, and Immunity - Health (Vol. 48). Elsevier Inc. https://doi.org/10.1016/j.bbih.2025.101049
Basgaran, A., Lymberopoulos, E., Burchill, E., Reis-Dehabadi, M., & Sharma, N. (2025). Machine learning determines the incidence of Alzheimer’s disease based on population gut microbiome profile. Brain Communications, 7(2). https://doi.org/10.1093/braincomms/fcaf059
Dong, Y., Wu, X., Zhang, Y., Hu, A., Zhou, Q., Yue, X., Liu, Z., & Li, M. (2025). The Role of Probiotics in Modulating the Gut Microbiome in Alzheimer’s Disease: A Review. In Foods (Vol. 14, Issue 9). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/foods14091531
Fan, K. C., Lin, C. C., Chiu, Y. L., Koh, S. H., Liu, Y. C., & Chuang, Y. F. (2025). Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer’s disease pathology. Alzheimer’s Research and Therapy, 17(1). https://doi.org/10.1186/s13195-025-01769-9
Flynn, C. M., Omoluabi, T., Janes, A. M., Rodgers, E. J., Torraville, S. E., Negandhi, B. L., Nobel, T. E., Mayengbam, S., & Yuan, Q. (2025). Targeting early tau pathology: probiotic diet enhances cognitive function and reduces inflammation in a preclinical Alzheimer’s model. Alzheimer’s Research and Therapy, 17(1). https://doi.org/10.1186/s13195-025-01674-1
Gasmi, M., Silvia Hardiany, N., van der Merwe, M., Martins, I. J., Sharma, A., & Williams-Hooker, R. (2025). The influence of time-restricted eating/feeding on Alzheimer’s biomarkers and gut microbiota. In Nutritional Neuroscience (Vol. 28, Issue 2, pp. 156–170). Taylor and Francis Ltd. https://doi.org/10.1080/1028415X.2024.2359868
Girodon, L., & Hauet, P. (2025). Le microbiote, un nouvel acteur dans le diagnostic de la maladie d’Alzheimer. Medecine/Sciences, 41(2), 195–197. https://doi.org/10.1051/medsci/2025019
Jabbari Shiadeh, S. M., Chan, W. K., Rasmusson, S., Hassan, N., Joca, S., Westberg, L., Elfvin, A., Mallard, C., & Ardalan, M. (2025). Bidirectional crosstalk between the gut microbiota and cellular compartments of brain: Implications for neurodevelopmental and neuropsychiatric disorders. In Translational Psychiatry (Vol. 15, Issue 1). Springer Nature. https://doi.org/10.1038/s41398-025-03504-2
Kang, J. W., Khatib, L. A., Heston, M. B., Dilmore, A. H., Labus, J. S., Deming, Y., Schimmel, L., Blach, C., McDonald, D., Gonzalez, A., Bryant, M., Ulland, T. K., Johnson, S. C., Asthana, S., Carlsson, C. M., Chin, N. A., Blennow, K., Zetterberg, H., Rey, F. E., & Bendlin, B. B. (2025). Gut microbiome compositional and functional features associate with Alzheimer’s disease pathology. Alzheimer’s and Dementia, 21(7). https://doi.org/10.1002/alz.70417
Koumpouli, D., Koumpouli, V., & Koutelidakis, A. E. (2025). The Gut–Brain Axis and Neurodegenerative Diseases: The Role of Nutritional Interventions Targeting the Gut Microbiome—A Systematic Review. In Applied Sciences (Switzerland) (Vol. 15, Issue 10). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/app15105558
Marizzoni, M., Mombelli, E., Alboni, S., Rosa, M., Moretti, D. V., Mirabelli, P., Coppola, L., Luongo, D., Salamone, D., Saleri, S., Piazza, F., Begni, V., Salvatore, M., Frisoni, G. B., & Cattaneo, A. (2026). Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation. Brain, Behavior, and Immunity, 131. https://doi.org/10.1016/j.bbi.2025.106138
Pfaffinger, J. M., Hays, K. E., Seeley, J., Ramesh Babu, P., & Ryznar, R. (2025). Gut dysbiosis as a potential driver of Parkinson’s and Alzheimer’s disease pathogenesis. In Frontiers in Neuroscience (Vol. 19). Frontiers Media SA. https://doi.org/10.3389/fnins.2025.1600148
Quansah, M., David, M. A., Martins, R., El-Omar, E., Aliberti, S. M., Capunzo, M., Jensen, S. O., & Tayebi, M. (2025). The Beneficial Effects of Lactobacillus Strains on Gut Microbiome in Alzheimer’s Disease: A Systematic Review. In Healthcare (Switzerland) (Vol. 13, Issue 1). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/healthcare13010074
Racette, S. B., Gunning, J. A., Eagan, D. E., Zaniletti, I., Smith, T. L., DeCuna, C. J., Hettiwatte, Y. S., Demeke, M. T., Khan, N. A., Aliskevich, E. L., Krell-Roesch, J., & Geda, Y. E. (2025). Time-restricted eating in Alzheimer’s disease: TREAD pilot trial design. Contemporary Clinical Trials Communications, 48. https://doi.org/10.1016/j.conctc.2025.101564
Sepúlveda-Rivera, V., Olivieri-Henry, G., Morales-González, H., Ruiz-Adames, J., Herrero-Rivera, C., Rentas-Echeverria, A., Cardona-Berdecia, V., Soler-Llompart, C., Sala-Morales, A. C., Pérez-Montero, G., Blanco-Ruiz, E., & Godoy-Vitorino, F. (2025). Gut microbiota distinguishes aging hispanics with Alzheimer’s disease: associations with cognitive impairment and severity. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-13262-2
Sharma, S., Bashir, B., Kolekar, K. A., Acharya, A., Gupta, M., Jena, R., Vishwas, S., Kaur, J., Gupta, G., Kumbhar, P. S., Patle, D., Chaitanya, M. V. N. L., Gulati, M., & Singh, S. K. (2025). Tailoring the biomarkers of Alzheimer’s disease using a gut microbiome-centric approach: Preclinical, clinical, and regulatory perspectives. In Ageing Research Reviews (Vol. 112). Elsevier Ireland Ltd. https://doi.org/10.1016/j.arr.2025.102888
Skawratananond, S., McCrea, G. E., Lie, P., Buxton, M. B., Daly, S. P., Vojtkofsky, N. A., Smith, S. C., Zhang, C., Hernandez, M., Hindle, A., Logsdon, A. F., & Lawrence, J. J. (2025). The synergistic interplay between vitamin A, dietary fiber, and the microbiota-gut-brain axis: a potential mechanism for preventing Alzheimer’s disease. In American Journal of Physiology - Gastrointestinal and Liver Physiology (Vol. 329, Issue 3, pp. G484–G499). American Physiological Society. https://doi.org/10.1152/ajpgi.00097.2025
Theis, B. F., Park, J. S., Kim, J. S. A., Zeydabadinejad, S., Vijay-Kumar, M., Yeoh, B. S., & Saha, P. (2025). Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease. In Biomedicines (Vol. 13, Issue 6). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/biomedicines13061357
Upadhyay, P., Kumar, S., Tyagi, A., Tyagi, A. R., Barbhuyan, T., & Gupta, S. (2025). Gut Microbiome rewiring via fecal transplants: Uncovering therapeutic avenues in Alzheimer’s disease models. BMC Neuroscience, 26(1). https://doi.org/10.1186/s12868-025-00953-9
Wang, T., Gao, C., Dong, X., & Li, L. (2025). Therapeutic potential of traditional chinese medicine polysaccharides in alzheimer’s disease via modulation of gut microbiota: A review. In International Journal of Biological Macromolecules (Vol. 321). Elsevier B.V. https://doi.org/10.1016/j.ijbiomac.2025.146160
Wu, D., Wang, H., Ni, Y., Lu, Y., Wang, Y., Li, H., & Chen, L. (2025). Decoding the gut–brain axis: toward AI-driven integration of neuroimaging and gut microbiota in human health. In Visual Computer (Vol. 41, Issue 12, pp. 9793–9804). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00371-025-04000-w
Zhao, H., Zhou, X., Song, Y., Zhao, W., Sun, Z., Zhu, J., & Yu, Y. (2025). Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer’s disease continuum. Alzheimer’s Research and Therapy, 17(1). https://doi.org/10.1186/s13195-025-01683-0
Zhou, X. P., Sun, L. B., Liu, W. H., Zhu, W. M., Li, L. C., Song, X. Y., Xing, J. P., & Gao, S. H. (2025). The complex relationship between gut microbiota and Alzheimer’s disease: A systematic review. In Ageing Research Reviews (Vol. 104). Elsevier Ireland Ltd. https://doi.org/10.1016/j.arr.2024.102637
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gabrielle Juliana Hartono
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License
This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercial purposes.
- Adaptation — mixing, changing, and developing materials for any purpose, even commercial ones.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
